IP Library › Granted Patent US 12,310,938
Granted Patent B2
US 12,310,938 · App. 18/117,059 · Granted May 27, 2025

Compositions and methods for weight loss maintenance

Inventors: Dominic Paul D'Agostino (Tampa, FL); Angela Marie Poff (Tampa, FL); Andrew Paul Koutnik (Tallahassee, FL)
Assignee: University of South Florida
A61K31/22A23L33/10A23L33/30A61K9/0056A61K31/19A61P3/04A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,310,938
App. No.
18/117,059
Granted
May 27, 2025
Kind
B2
Abstract

Compositions and methods for inducing weight loss, fat loss, maintaining weight or fat loss, suppressing appetite, reducing calorie intake, reducing weight gain, decreasing feed efficiency, increasing metabolic inefficiency, increasing energy expenditure, increasing thermogenesis and/or resetting metabolic set are disclosed. The compositions have a therapeutically effective amount of a ketogenic supplement, e.g., a ketone diesters, such as R,S 1,3-butanediol diacetoacetate. Compositions of one or more beta-hydroxy butyrate, beta-hydroxybutyrate salt, and medium chain triglycerides are also disclosed.

Claims (11)

1. A method of inducing weight loss, inducing fat loss, and/or maintaining the weight or fat loss, comprising:

administering a therapeutically effective amount of a composition comprising R,S 1,3-butanediol diacetoacetate diester and a pharmaceutically acceptable carrier,

wherein the composition is a food with about 10-30% by weight R,S 1,3-butanediol diacetoacetate diester.

2. The method of claim 1 , wherein the weight loss is maintained even after stopping administration of the composition.

3. The method of claim 1 , wherein the composition further comprises one or more beta-hydroxybutyrate, beta-hydroxybutyrate salt, or medium chain triglycerides.

4. The method of claim 1 , further comprising administering to the patient one or more beta-hydroxybutyrate, beta-hydroxybutyrate salt, or medium chain triglycerides.

5. The method of claim 1 , wherein the R,S 1,3 butanediol acetoacetate diester is in an amount sufficient to maintain the weight or fat loss after cessation of administration of the composition.

6. The method of claim 1 , wherein the patient is obese, one who is preparing for or has undergone surgery for weight loss, one who has previously undergone a weight loss program, one who has had their weight cycled, a type-2 diabetic, has low thyroid hormone, has a metabolic syndrome, maintained a low caloric intake for extended periods, or who have reduced energy expenditure.

7. The method of claim 1 , wherein the food is a snack food, nutritional bar, protein bar, or beverage.

8. The method of claim 1 , wherein the pharmaceutically acceptable carrier is a liquid pharmaceutical carrier comprising water, milk, or juice.

9. The method of claim 1 , wherein the composition has from 0.5 to 300 g of R,S 1,3-butanediol diacetoacetate diester.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2023
From: D'AGOSTINO, DOMINIC PAUL; POFF, ANGELA MARIE; KOUTNIK, ANDREW PAUL
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 062875/0513 →
Continuity (4)
Continuation 16772490
Provisional Application 62597640 · Dec 12, 2017
Provisional Application 62630492 · Feb 14, 2018
Related Publication 20230285348A1 · Sep 14, 2023
References Cited (24)
US 10646462B2 · D'Agostino · 2020 [cited by examiner]
US 11596616B2 · D'Agostino · 2023 [cited by examiner]
US 20140350105A1 · D'Agostino · 2014 [cited by applicant]
US 20160317487A1 · D'Agostino et al. · 2016 [cited by applicant]
US 20170000754A1 · Weeber et al. · 2017 [cited by applicant]
US 20170172969A1 · D'Agostino · 2017 [cited by applicant]
US 20170266148A1 · D'Agostino et al. · 2017 [cited by applicant]
US 20180213833A1 · Gupta · 2018 [cited by applicant]
EP 0318357A2 · 1989 [cited by applicant]
WO WO2014153416A1 · 2014 [cited by examiner]
WO WO2015156865A1 · 2015 [cited by examiner]
International Search Report and Written Opinion in PCT/US2018/065244. Mailed Mar. 22, 2019. 12 pages. [cited by applicant]
Wikipedia, “Cellular respiration”, Nov. 8, 2017. Retrieved on Feb. 19, 2019 from https://en.wikipedia.org/w/index.php?title=Cellulauespiration&oldid=809379518. [cited by applicant]
Romsos DR., Butanediol and lipid metabolism. Federation Proceedings [Nov. 1, 1975, 34(12):2186-2190]. [cited by applicant]
Romsos DR., Influence of dietary 1,3 butanediol on weight gain, blood, and liver metabolites and lipogenesis in the pig and chick. Journal of Nutrition. Mar. 1975. [cited by applicant]
WHO Food Additives Series 14, 467, Butane-1,3-diol. Retrieved from http://www.inchem.org/documents/jecfa/jecmono/v14je03.htm on Nov. 30, 2017. [cited by applicant]
Scala, R.A. and Paynter, O.E., Chronic oral toxicity of 1,3-butanediol, Toxicology and Applied Pharmacology, 1967, 10, 1:160-164. [cited by applicant]
Extended European Search Report in PCT/US2018/065244. Mailed Jul. 20, 2021. 9 pages. [cited by applicant]
Kesl, Shannon L. et al. “Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotei levels in Sprague-Dawley rats.” Nutrition & Metabolism, vol. 13, No. 9 (2016). [cited by applicant]
Tashim, Sami A. et al. “Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester.” Journal of Lipid Research, vol. 55, No. 9. (2014). [cited by applicant]
Desrochers, Sylvain et al. “R, S-1, 3-butanediol acetoacetate esters, potential alternatives to lipid emulsions for total parenteral nutrition.” The Journal of Nutritional Biochemistry, vol. 6, No. 2 (1995). [cited by applicant]
Kennedy, Adam R. et al. “A high-fat, ketogenic diet induces a unique metabolic state in mice.” American Journal of Physiology: Endocrinology and Metabolism, vol. 292, No. 6 (2007). [cited by applicant]
Desrochers, S. et al. “Metabolism of (R,S)-1,3-butanediol acetoacetate esters, potential parenteral and enteral nutrients in conscious pigs.” American Journal of Physiology: Endocrinology and Metabolism, vol. 268 (1995). [cited by applicant]
Vandenberghe, Camille, et al. “Caffeine intake increases plasma ketones: an acute metabolic study in humans.” Canadian journal of physiology and pharmacology 95.4 (2017): 455-458. [cited by applicant]